Literature DB >> 18989115

The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.

Ian R A Mackenzie1, Rosa Rademakers.   

Abstract

PURPOSE OF REVIEW: We examine current evidence that the transactive response DNA-binding protein (TDP-43) plays a pathogenic role in both amyotrophic lateral sclerosis and frontotemporal dementia. RECENT
FINDINGS: TDP-43 was recently identified as the major pathological protein in sporadic amyotrophic lateral sclerosis and in the most common pathological subtype of frontotemporal dementia, frontotemporal lobar degeneration with ubiquitinated inclusions. In these conditions, abnormal C-terminal fragments of TDP-43 are ubiquitinated, hyperphosphorylated and accumulate as cellular inclusions in neurons and glia. Cells with inclusions show absence of the normal nuclear TDP-43 localization. Recently, missense mutations in the gene encoding TDP-43 have been identified in patients with sporadic and familial amyotrophic lateral sclerosis.
SUMMARY: The recent discovery of pathological TDP-43 in both amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitinated inclusions confirms that these are closely related conditions within a new biochemical class of neurodegenerative disease, the TDP-43 proteinopathies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989115      PMCID: PMC2869081          DOI: 10.1097/WCO.0b013e3283168d1d

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  62 in total

1.  Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O M Hardiman
Journal:  Arch Neurol       Date:  2000-08

2.  TDP-43 A315T mutation in familial motor neuron disease.

Authors:  Michael A Gitcho; Robert H Baloh; Sumi Chakraverty; Kevin Mayo; Joanne B Norton; Denise Levitch; Kimmo J Hatanpaa; Charles L White; Eileen H Bigio; Richard Caselli; Matt Baker; Muhammad T Al-Lozi; John C Morris; Alan Pestronk; Rosa Rademakers; Alison M Goate; Nigel J Cairns
Journal:  Ann Neurol       Date:  2008-02-20       Impact factor: 10.422

3.  Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS.

Authors:  Ilse Gijselinck; Kristel Sleegers; Sebastiaan Engelborghs; Wim Robberecht; Jean-Jacques Martin; Rik Vandenberghe; Raf Sciot; Bart Dermaut; Dirk Goossens; Julie van der Zee; Tim De Pooter; Jurgen Del-Favero; Patrick Santens; Peter De Jonghe; Peter P De Deyn; Christine Van Broeckhoven; Marc Cruts
Journal:  Neurobiol Aging       Date:  2008-01-10       Impact factor: 4.673

4.  TDP-43 mutation in familial amyotrophic lateral sclerosis.

Authors:  Akio Yokoseki; Atsushi Shiga; Chun-Feng Tan; Asako Tagawa; Hiroyuki Kaneko; Akihide Koyama; Hiroto Eguchi; Akira Tsujino; Takeshi Ikeuchi; Akiyoshi Kakita; Koichi Okamoto; Masatoyo Nishizawa; Hitoshi Takahashi; Osamu Onodera
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

5.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.

Authors:  Brian S Johnson; J Michael McCaffery; Susan Lindquist; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

6.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

7.  TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study.

Authors:  Kimmo J Hatanpaa; Eileen H Bigio; Nigel J Cairns; Kyle B Womack; Sandra Weintraub; John C Morris; Chan Foong; Guanghua Xiao; Christa Hladik; Tina Y Mantanona; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

8.  TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression.

Authors:  Youhna M Ayala; Tom Misteli; Francisco E Baralle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

9.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.

Authors:  Vivianna M Van Deerlin; James B Leverenz; Lynn M Bekris; Thomas D Bird; Wuxing Yuan; Lauren B Elman; Dana Clay; Elisabeth McCarty Wood; Alice S Chen-Plotkin; Maria Martinez-Lage; Ellen Steinbart; Leo McCluskey; Murray Grossman; Manuela Neumann; I-Lin Wu; Wei-Shiung Yang; Robert Kalb; Douglas R Galasko; Thomas J Montine; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Chang-En Yu
Journal:  Lancet Neurol       Date:  2008-04-07       Impact factor: 44.182

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

View more
  50 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Neurotoxic effects of TDP-43 overexpression in C. elegans.

Authors:  Peter E A Ash; Yong-Jie Zhang; Christine M Roberts; Tassa Saldi; Harald Hutter; Emanuele Buratti; Leonard Petrucelli; Christopher D Link
Journal:  Hum Mol Genet       Date:  2010-06-08       Impact factor: 6.150

3.  rs5848 polymorphism and serum progranulin level.

Authors:  Ging-Yuek R Hsiung; Alice Fok; Howard H Feldman; Rosa Rademakers; Ian R A Mackenzie
Journal:  J Neurol Sci       Date:  2010-11-02       Impact factor: 3.181

Review 4.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

Review 5.  L-Serine: a Naturally-Occurring Amino Acid with Therapeutic Potential.

Authors:  J S Metcalf; R A Dunlop; J T Powell; S A Banack; P A Cox
Journal:  Neurotox Res       Date:  2017-09-19       Impact factor: 3.911

Review 6.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

Review 7.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

Review 8.  Recent insights into the molecular genetics of dementia.

Authors:  Rosa Rademakers; Anne Rovelet-Lecrux
Journal:  Trends Neurosci       Date:  2009-07-27       Impact factor: 13.837

Review 9.  Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery.

Authors:  Tongyin Zheng; Yiran Yang; Carlos A Castañeda
Journal:  Biochem J       Date:  2020-09-30       Impact factor: 3.857

10.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

Authors:  Andrea D'Ambrogio; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Maurizio Romano; Youhna M Ayala; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.